U.S. Federal Appeals Court Upholds $25m Monsanto Roundup Cancer Verdict

Rhea-AI Summary

A federal appellate court's ruling upheld findings that Bayer AG's Monsanto Roundup caused a California man's non-Hodgkins lymphoma, impacting Bayer's efforts to finalize a settlement for over 90,000 pending cancer lawsuits. The ruling confirms the causal link between Roundup and cancer, with previous jury awards totaling $5 million in compensatory damages and $75 million in punitive damages, later reduced to $20 million. Critics argue the proposed settlement limits future legal options for cancer victims. A hearing on the settlement is scheduled for May 19.

Positive

• Court ruling confirms evidence linking Roundup to cancer, strengthening cases against Bayer.

Negative

• The ruling complicates Bayer's proposed settlement for over 90,000 pending lawsuits, risking further litigation exposure.
• The current settlement proposal has drawn criticism for limiting future legal options for cancer victims.

SAN FRANCISCO, May 14, 2021 /PRNewswire/ -- A federal appellate ruling upholding findings that Bayer AG's Monsanto Roundup weed killer caused a California man's non-Hodgkins lymphoma cancer deals a blow to efforts by Bayer AG to push through a flawed settlement of thousands of pending cancer lawsuits, trial lawyers with Dallas-based Fears Nachawati Law Firm said Friday.

Fears Nachawati lawyers, who represent more than 4,000 cancer victims in litigation against Bayer AG (OTCMKTS: BAYRY), will discuss the significance of the ruling in Hardeman v. Monsanto and the status of the proposed settlement during a Facebook Live news conference on Monday at 11 a.m. Central. Click here for details: https://bit.ly/3bramVi

"This resounding victory for cancer victims could not have come at a worse time for Bayer as it tries to steamroll plaintiffs into accepting a flawed and unfair settlement," said Fears Nachawati co-founder Majed Nachawati. "Everyone now has a better understanding of the value of these cases and the exposure Bayer faces if it does not reach a fair settlement and resolve all outstanding lawsuits."

Friday's ruling stems from a 2019 jury verdict finding that plaintiff Edwin Hardeman developed non-Hodgkins lymphoma after exposure to Roundup. The verdict included $5 million in compensatory damages and $75 million in punitive damages, which were later reduced to $20 million.

The ruling has implications for Bayer's efforts to settle more than 90,000 pending cancer lawsuits, which have drawn criticism from thousands of plaintiffs. Among other things, the settlement would allow Bayer to continue selling Roundup but limit legal options for individuals diagnosed with cancer in the future. A hearing on the settlement is set for May 19.

"We now have a federal appellate court supporting evidence that Roundup causes cancer and that Bayer had a duty to warn consumers," Mr. Nachawati said. "Shareholders need to know that these lawsuits will not stop until Bayer makes a meaningful settlement offer."

Dallas-based Fears | Nachawati Law Firm represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation and individual victims in complex personal injury litigation. The largest and most diverse products liability law firm in the nation, Fears | Nachawati was ranked No. 1 nationally in product liability filings in federal court over the last three years. For more information, visit https://www.fnlawfirm.com.  

Media Contact:
Robert Tharp  
214-420-6011
robert@androvett.com  

View original content:http://www.prnewswire.com/news-releases/us-federal-appeals-court-upholds-25m-monsanto-roundup-cancer-verdict-301291968.html

SOURCE Fears Nachawati Law Firm

FAQ

What was the recent court ruling regarding Bayer AG and Roundup?

A federal appellate court upheld a ruling that Bayer AG's Roundup caused a man's non-Hodgkins lymphoma, complicating Bayer's settlement efforts.

What implications does the ruling have for Bayer AG's lawsuits?

The ruling could hinder Bayer's negotiations over 90,000 pending cancer lawsuits, emphasizing the need for a fair settlement.

What are the damages awarded in the Hardeman case against Bayer AG?

The initial jury awarded $5 million in compensatory damages and $75 million in punitive damages, later reduced to $20 million.

When is the hearing for Bayer AG's proposed settlement?

The hearing for Bayer AG's proposed settlement is scheduled for May 19.

What concerns do plaintiffs have about Bayer AG's settlement proposal?

Plaintiffs are concerned that the settlement limits their future legal options if diagnosed with cancer.